Alejandro Fonollosa

TL;DR: Anti-TNF-α therapy is effective and relatively safe in refractory BD uveitis and the best-corrected visual acuity and the suppression load also showed significant improvement.

TL;DR: Anti-TNF-α therapy is effective in sarcoid uveitis patients refractory to conventional immunosuppressive therapy and a substantial reduction in prednisone dose despite having failed standard therapy is observed.

TL;DR: A functionally distinct combination of ERAP1 and ERAP2 are a hallmark of Bird shot and provide rationale for strategies designed to correct ERAP function for treatment of Birdshot and MHC‐I‐opathies more broadly.

TL;DR: The association between the HLA region and non-infectious non-anterior uveitis is further interrogated and a new non-HLA susceptibility factor is identified and proposed additional risk loci with putative roles in this complex condition.

TL;DR: Starting ADA in nonbiotherapy-naive patients was a predictor for "discontinuation due to inefficacy," whereas undifferentiated uveitis was a Predictor for " Discontinuations due to adverse event." drug retention time was significantly shorter when spared or intensified, mainly due to discontinuation after sustained quiescence.